FDA Adverse Event Injury Summary report: N

LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM (UNK SIZE)

MDR report key: 2326118 · Received November 2, 2011

Report

Report Number
2024601-2011-00932
Event Type
Injury
Date Received
November 2, 2011
Date of Event
April 9, 2011
Report Date
October 4, 2011
Manufacturer
ALLERGAN
Product Code
LTI
PMA / PMN Number
P000008
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
NO INFORMATION

Narratives

Additional Manufacturer Narrative · 1

TAPER UNK. (B)(4). THE REPORTER OF THE COMPLAINT WAS ASKED TO RETURN THE PRODUCT FOR ANALYSIS AS WELL AS INDICATE THE PRODUCT SERIAL NUMBER, DATE OF EVENT, IMPLANT DATE AND EXPLANT DATE. MULTIPLE REQUESTS FOR FURTHER INFO HAVE BEEN MADE. ALLERGAN HAS RECEIVED NO RESPONSE FROM THE AUTHORS. VISUAL EXAMINATION MAY DETERMINE THE CONNECTOR TYPE ASSOCIATED WITH THIS REPORT. ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME. THEREFORE NO ANALYSIS OR TESTING HAS BEEN DONE. DEVICE LABELING ADDRESSES THE REPORTED EVENTS OF BAND RELATED COMPLICATIONS AS FOLLOWS: "IT IS IMPORTANT TO DISCUSS ALL POSSIBLE COMPLICATIONS AND ADVERSE EVENTS WITH YOUR PATIENT. COMPLICATIONS WHICH MAY RESULT FROM THE USE OF THIS PRODUCT INCLUDE THE RISKS ASSOCIATED WITH THE MEDICATIONS AND METHODS UTILIZED IN THE SURGICAL PROCEDURE, THE RISKS ASSOCIATED WITH ANY SURGICAL PROCEDURE AND THE PT'S DEGREE OF INTOLERANCE TO ANY FOREIGN OBJECT IMPLANTED IN THE BODY."

Description of Event or Problem · 1

DOCTOR REPORTED EVENTS OF "AND RELATED COMPLICATIONS" FROM JOURNAL ARTICLE: "LAPAROSCOPIC GASTRIC BYPASS FOR FAILURE OF ADJUSTABLE GASTRIC BANDING: A REVIEW OF 85 CASES", OBES SURG (2011) 21:1513-1519. THE DEFINITION OF EACH OF THESE COMPLICATIONS IS NOT EVIDENT FROM THE ARTICLE. ALTHOUGH THE MFR OF THE DEVICE IS UNK, IT IS ALLERGAN'S APPROACH TO COMPLIANCE TO RESOLVE ALL DOUBT IN FAVOR OF REPORTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM (UNK SIZE) LTI ALLERGAN NA NI

Patients

Seq Age Sex Outcome Treatment
1 NI Required Intervention